Open access · CC-BY
via OpenAlex
Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective
Virginia Boccardi, Francesca Mancinetti, Patrizia Mecocci
Antioxidants · 2025 · ▲ 34 citations
Loss of proteostasis
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Human
Preclinical / animal
Review
Abstract
Neurodegenerative diseases such as Alzheimer's disease (AD) are closely linked to oxidative stress and advanced glycation end products (AGEs), two interrelated processes that exacerbate neuronal damage through mitochondrial dysfunction(definition), protein aggregation, and chronic inflammation. This narrative review explores the metabolic interplay between reactive oxygen species (ROS) and AGEs, with a focus on the AGE-RAGE (receptor for advanced glycation end products) signaling axis as a driver of neurodegeneration. Evidence from preclinical and clinical studies highlights their combined role in disease progression and underscores potential therapeutic targets. Strategies including mitochondria-targeted antioxidants, AGE inhibitors, RAGE antagonists, and metabolic interventions are discussed, along with future directions for biomarker development and personalized treatments. This review integrates current molecular insights into a unified metabolic-inflammatory model of AD, highlighting translational therapeutic opportunities.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/antiox14091044
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Boccardi, V., Mancinetti, F., & Mecocci, P. (2025). Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective. <em>Antioxidants</em>. https://doi.org/10.3390/antiox14091044
Vancouver
Boccardi V, Mancinetti F, Mecocci P. Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective. Antioxidants. 2025. doi:10.3390/antiox14091044.
BibTeX
@article{virginia2025Oxidat,
title = {Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective},
author = {Virginia Boccardi and Francesca Mancinetti and Patrizia Mecocci},
journal = {Antioxidants},
year = {2025},
doi = {10.3390/antiox14091044},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Narra J 2026
Open access · OA
Oxidative stress as a converging mechanism of aging and neurodegeneration: From molecular pathways to therapeutic targets.
Biomedicines 2023
Open access · CC-BY
Oxidative Stress in Health and Disease
Cells 2025
Open access · CC-BY
Mitochondrial Dysfunction in Neurodegenerative Diseases
Redox Biology 2014
Open access · CC-BY
Role of advanced glycation end products in cellular signaling
International journal of molecular sciences 2026
Citation only
Exploring Pathophysiological Processes Shared Between Type 2 Diabetes Mellitus and Osteoarthritis.
Basic & clinical pharmacology & toxicology 2026
Open access · OA